Biology is becoming engineerable
we are investing in a future where bioengineering has industrial scale and speed, and today’s barely conceivable medicines are routine
We partner with innovators
building groundbreaking companies with the following characteristics
Advanced or emerging therapeutic platform
novel biologics, cell therapies, gene therapies, and precision small molecules
Treating or curing life-threatening diseases
cardiovascular, infectious, neurologic, oncologic, rheumatologic, and other serious diseases
High-resolution, high-throughput biology
computational drug discovery, novel screening and imaging tools, and multi-omics that accelerate discovery
Designing for manufacturability
appropriate manufacturing at each stage of development
Reaching Human
Proof-Of-Concept
long-term partnerships with companies from pre-IND to commercialization
“
At the base of the creativity of all large familiar forms of life, symbiosis generates novelty. It brings together different life-forms, always for a reason.”